Mechanisms, consequences, and prevention of coronary graft failure

M Gaudino, C Antoniades, U Benedetto, S Deb… - Circulation, 2017 - Am Heart Assoc
Graft failure occurs in a sizeable proportion of coronary artery bypass conduits. We herein
review relevant current evidence to give an overview of the incidence, pathophysiology, and …

Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions

RE Harskamp, RD Lopes, CE Baisden… - Annals of …, 2013 - journals.lww.com
Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …

The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting

GS Aldea, FG Bakaeen, J Pal, S Fremes… - The Annals of thoracic …, 2016 - Elsevier
Internal thoracic arteries (ITAs) should be used to bypass the left anterior descending (LAD)
artery when bypass of the LAD is indicated (class of recommendation [COR] I, level of …

Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical …

Q Zhao, Y Zhu, Z Xu, Z Cheng, J Mei, X Chen, X Wang - Jama, 2018 - jamanetwork.com
Importance The effect of ticagrelor with or without aspirin on saphenous vein graft patency in
patients undergoing coronary artery bypass grafting (CABG) is unknown. Objective To …

Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a …

JH Alexander - JAMA: Journal of the American Medical …, 2005 - search.ebscohost.com
Context Coronary artery bypass graft (CABG) surgery with autologous vein grafting is
commonly performed. Progressive neointimal hyperplasia, however, contributes to …

Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV

CN Hess, RD Lopes, CM Gibson, R Hager… - Circulation, 2014 - Am Heart Assoc
Background—Coronary artery bypass grafting success is limited by vein graft failure (VGF).
Understanding the factors associated with VGF may improve patient outcomes. Methods and …

Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis

K Solo, S Lavi, C Kabali, GN Levine, A Kulik… - bmj, 2019 - bmj.com
Objective To assess the effects of different oral antithrombotic drugs that prevent saphenous
vein graft failure in patients undergoing coronary artery bypass graft surgery. Design …

Coronary vein graft disease: pathogenesis and prevention

P Parang, R Arora - Canadian Journal of Cardiology, 2009 - Elsevier
Not long after coronary artery bypass grafting surgery was described, several reports
presented follow-up angiographic data on large cohorts of patients, demonstrating that …

Techniques and standards in intraoperative graft verification by transit time flow measurement after coronary artery bypass graft surgery: a critical review

L Niclauss - European Journal of Cardio-Thoracic Surgery, 2017 - academic.oup.com
Transit time flow measurement (TTFM) is a quality control tool for intraoperative graft
evaluation in coronary artery bypass graft (CABG) surgery. A critical review of the literature …

Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery

RD Lopes, RH Mehta, GE Hafley, JB Williams… - Circulation, 2012 - Am Heart Assoc
Background—Vein graft failure (VGF) is common after coronary artery bypass graft surgery,
but its relationship with long-term clinical outcomes is unknown. In this retrospective …